R R - American Society of Gene & Cell Therapy

More documents

Recommendations

Info

The American Society of Gene Therapy’s 2004 7th Annual Meeting final program Faculty List Jeffrey L. Spees, PhD Tulane University Health Sciences Center New Orleans, Louisiana Patrick Squiban, MD Transgene Medical Affairs Strasbourg, France Arun Srivastava, PhD Indiana University School of Medicine Indianapolis, Indiana George Stamatoyannopoulos, MD University of Washington Seattle, Washington Daniel H. Sterman, MD University of Pennsylvania Medical Center Philadelphia, Pennsylvania David Strayer, MD, PhD Jefferson Medical College Philadelphia, Pennsylvania Lorenz Studer, MD Memorial Sloan-Kettering Cancer Center New York, New York Sean M. Sullivan, PhD University of Florida College of Pharmacy Gainesville, Florida Geoff Symonds, PhD Johnson & Johnson Research Sydney, Australia Francis C. Szoka, Jr, PhD University of California San Francisco San Francisco, California Michael Themis, PhD Imperial College London, United Kingdom Didier Trono, MD University of Geneva Geneva, Switzerland Jeffrey Ulmer, PhD Chiron Vaccines Emeryville, California Catherine Verfaillie, MD University of Minnesota Minneapolis, Minnesota Inder Verma, PhD The Salk Institute La Jolla, California Richard G. Vile, PhD Mayo Clinic Rochester, Minnesota Christof von Kalle, MD Cincinnati Children’s Hospital Research Foundation Cincinnati, Ohio Samuel C. Wadsworth, PhD Genzyme Corporation Framingham, Massachusetts Christopher Walsh, MD, PhD Mount Sinai School of Medicine New York, New York Guoshun Wang, DVM, PhD Louisiana State University Health Sciences Center New Orleans, Louisiana Kenneth H. Warrington, Jr, PhD University of Florida Gainesville, Florida Deborah J. Watson, PhD University of Pennsylvania Philadelphia, Pennsylvania Daniel Weiss, MD, PhD University of Vermont Health Science Research Facility Burlington, Vermont Volkmar Weissig, PhD Northeastern University Boston, Massachusetts Matthew Weitzman, PhD The Salk Institute San Diego, California Jennifer L. West, PhD Rice University Houston, Texas Katie Whartenby, PhD Johns Hopkins University School of Medicine Baltimore, Maryland James M. Wilson, MD, PhD University of Pennsylvania Philadelphia, Pennsylvania William Wold, PhD St. Louis University School of Medicine St. Louis, Missouri Jon Wolff, MD University of Wisconsin Madison Madison, Wisconsin Savio L.C. Woo, PhD Mount Sinai School of Medicine New York, New York Xiao Xiao, PhD University of Pittsburgh Pittsburgh, Pennsylvania Yuhong Xu, PhD Shanghai Jiaotong University Shanghai, Peoples Republic of China Vijay K. Yechoor, MD Baylor College of Medicine Houston, Texas Seppo Yla-Herttuala, MD, PhD University of Kuopio Kuopio, Finland Mervin Yoder, MD Cancer Research Institute Indiana University School of Medicine Indianapolis, Indiana DC Yu, PhD Cell Genesys, Incorporated South San Francisco, California Joseph Zabner, MD University of Iowa Iowa City, Iowa Kurt R. Zinn, DVM, PhD University of Alabama at Birmingham Birmingham, Alabama 19
The American Society of Gene Therapy’s 2004 7th Annual Meeting final program General Meeting Information American Society of Gene Therapy The American Society of Gene Therapy (ASGT) is the largest medical professional organization representing researchers and scientists dedicated to discovering new gene therapies. ASGT was established in 1996, and has approximately 2,500 members from around the world. ASGT is committed to: • promoting and fostering the exchange and dissemination of information and ideas related to gene therapy; • encouraging excellence in research in the field of gene therapy; and • promoting professional and public education in all areas of gene therapy. Needs Clinical gene transfer has become increasingly complex due to ongoing developments in the fields of gene therapy itself, together with bioethics, research integrity, and financial conflicts, as well as new federal mandates, regulations, and guidelines. This meeting will provide an educational forum for researchers, scientists, and clinical investigators to expand their knowledge about the broad developments in these fields. Goals The goals of ASGT are to engage in scientific and educational activities in order to promote and foster the exchange of information and ideas relating to gene therapy, to encourage the general field of research involving gene therapy, and to promote professional and public education in all areas of gene therapy. The ASGT 7 th Annual Meeting will serve as a comprehensive forum to achieve these goals. Educational Objectives At the conclusion of the activity, the participant should be able to: • Discuss key aspects of the current laboratory and/ or clinical research in gene therapy. • Demonstrate knowledge of methods being used by gene therapy researchers and practitioners. • Describe one or more stimulating new areas of inquiry in the area of gene therapy. • Demonstrate familiarity with federal regulations and guidelines for clinical gene transfer studies. Educational Methods and Materials Lectures, Case Presentations, Panel Discussions, Question and Answer Sessions, Workshops, Audio/Visual Presentations, Abstracts, Posters, Executive Summary Target Audience The target audience includes basic science and translational researchers, clinical investigators, physicians, employees of federal government and regulatory agencies, postdoctoral fellows, graduate students, and other healthcare professionals with an interest in the latest advancements in the field of gene therapy. Evaluation Method Evaluation by questionnaire will address program content, presentation, and possible bias. Evaluations Please take time to complete the evaluation forms distributed at each session you attend. Your input and comments are essential in planning future educational sessions. When completed, evaluations can be returned to the ushers assigned to your session, any ASGT staff person, or dropped in the evaluation collection boxes located throughout the Convention Center. Accreditation/Credit Designation This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Baylor College of Medicine and the American Society of Gene Therapy. Baylor College of Medicine is accredited by the ACCME to provide continuing medical education for physicians. Baylor College of Medicine designates this educational activity for a maximum of 30.25 category 1 credits toward the AMA Physician’s Recognition Award. Each physician should claim only those credits that he/she actually spent in the activity. Disclosure It is the policy of Baylor College of Medicine (Baylor) that the provider and faculty/presenters disclose any significant financial or other relationships with commercial companies whose products may be discussed in the activity, or the commercial supporters, if any. Baylor also requires that faculty disclose any unlabeled use or investigational use (not yet approved for any purpose) of pharmaceutical and medical device products. Specific disclosure will be made to the participants prior to the educational activity. Faculty, topics, program schedule, and credit are subject to change. Audio or videotaping is prohibited without written permission from the Program Director and the Office of Continuing Medical Education, Baylor College of Medicine, Houston, Texas. 20
Page 1 and 2: The American Society of Gene Therap
Page 19: The American Society of Gene Therap
Page 43 and 44: - The American Society of Gene Ther
Page 71 and 72:
The American Society of Gene Therap
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
Page 157:
show all

R R - American Society of Gene & Cell Therapy

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?